1. Home
  2. MSBI vs DNA Comparison

MSBI vs DNA Comparison

Compare MSBI & DNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MSBI
  • DNA
  • Stock Information
  • Founded
  • MSBI 1881
  • DNA 2008
  • Country
  • MSBI United States
  • DNA United States
  • Employees
  • MSBI N/A
  • DNA N/A
  • Industry
  • MSBI Major Banks
  • DNA Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • MSBI Finance
  • DNA Health Care
  • Exchange
  • MSBI Nasdaq
  • DNA Nasdaq
  • Market Cap
  • MSBI 437.3M
  • DNA 466.4M
  • IPO Year
  • MSBI 2016
  • DNA N/A
  • Fundamental
  • Price
  • MSBI $16.88
  • DNA $6.94
  • Analyst Decision
  • MSBI Hold
  • DNA Sell
  • Analyst Count
  • MSBI 3
  • DNA 3
  • Target Price
  • MSBI $21.33
  • DNA $9.67
  • AVG Volume (30 Days)
  • MSBI 134.5K
  • DNA 1.1M
  • Earning Date
  • MSBI 07-24-2025
  • DNA 05-06-2025
  • Dividend Yield
  • MSBI 7.36%
  • DNA N/A
  • EPS Growth
  • MSBI N/A
  • DNA N/A
  • EPS
  • MSBI N/A
  • DNA N/A
  • Revenue
  • MSBI $174,721,000.00
  • DNA $237,417,000.00
  • Revenue This Year
  • MSBI $83.04
  • DNA N/A
  • Revenue Next Year
  • MSBI $0.85
  • DNA $15.26
  • P/E Ratio
  • MSBI N/A
  • DNA N/A
  • Revenue Growth
  • MSBI N/A
  • DNA 13.76
  • 52 Week Low
  • MSBI $14.79
  • DNA $5.00
  • 52 Week High
  • MSBI $28.08
  • DNA $23.29
  • Technical
  • Relative Strength Index (RSI)
  • MSBI 43.53
  • DNA 44.32
  • Support Level
  • MSBI $16.29
  • DNA $6.65
  • Resistance Level
  • MSBI $17.39
  • DNA $7.62
  • Average True Range (ATR)
  • MSBI 0.55
  • DNA 0.51
  • MACD
  • MSBI -0.16
  • DNA -0.08
  • Stochastic Oscillator
  • MSBI 22.01
  • DNA 16.34

About MSBI Midland States Bancorp Inc.

Midland States Bancorp Inc is a diversified financial holding company. The company provides a full range of commercial and consumer banking products and services, business equipment financing, merchant credit card services, trust and investment management, and insurance and financial planning services. The Banking segment which generates the majority of the revenue, provides a wide range of financial products and services to consumers and businesses, including commercial, commercial real estate, mortgage and other consumer loan products; commercial equipment financing etc. The Wealth Management segment consists of trust and fiduciary services, brokerage and retirement planning services. The Other segment includes the operating results of the parent company.

About DNA Ginkgo Bioworks Holdings Inc.

Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering: where company provide biological R&D services for customers across a range of industries and Biosecurity: where it provide services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment.

Share on Social Networks: